Closed · W81XWH-21-PRARP-LEAP-INCASA · CFDA 12.420 · Discretionary
DOD Peer Reviewed Alzheimer’s, Leveraging Approaches for Innovation in Care and Support Award
Federal grant opportunity posted by Defense Health Agency Contracting Activity - DHACA, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- July 21, 2021
- Close date
- 1
- Expected awards
The verdict
DOD Peer Reviewed Alzheimer’s, Leveraging Approaches for Innovation in Care and Support Award is a closed discretionary listing from Defense Health Agency Contracting Activity - DHACA that offered Varies by applicant across 1 expected award. Future funding cycles may be published under the same CFDA number.
- Varies
- award range
- Closed
- application status
- 1
- expected award
- 12.420
- CFDA program
Opportunity snapshot. This Grants.gov announcement - DOD Peer Reviewed Alzheimer’s, Leveraging Approaches for Innovation in Care and Support Award - is cataloged under number W81XWH-21-PRARP-LEAP-INCASA and tied to CFDA assistance listing 12.420, posted by Defense Health Agency Contracting Activity - DHACA. Grants.gov currently shows the opportunity as closed, first posted on April 8, 2021. The funding category is Discretionary, delivered as a grant.
Award economics. The award range on file is Varies by applicant. The agency has projected $15.0 million in total estimated funding for this announcement. It expects to issue 1 award. If the agency funds the expected 1 award from the $15.0 million estimated pool, the average award works out to roughly $15.0 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on July 21, 2021. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
Varies by applicant
Close Date
July 21, 2021
Posted
April 8, 2021
Est. Total Funding
$15,000,000
Expected Awards
1
Instrument
Grant
Description
The intent of the FY21 PRARP LEAP-InCASA is to support innovative and impactful research that improves the quality of life and care for individuals, families, and care providers living with AD/ADRD. The proposed work should innovatively challenge existing research paradigms or exhibit high levels of creativity within the context of the PRARP’s mission and vision. This can include innovations and research for symptom reduction (e.g., cognitive, behavioral, function, mood), resiliency factors, increasing or maintaining independence, and support for families and care providers.The FY21 PRARP LEAP-InCASA supports multi-institutional, harmonized research initiatives. As such, applications to the FY21 PRARP LEAP-InCASA require a Coordinating Center and a minimum of two Partnering Sites, representing at least three separate institutions within the application package. While the Coordinating Center provides overall infrastructure and support, each Partnering Site should develop its own unique research initiative that will be part of the overall project. The application should also demonstrate the study team’s experience in both military risk factor-related research and AD/ADRD as suited to the proposed work. Given the patient-centered intent of the FY21 PRARP LEAP-InCASA, animal research is prohibited.Role of the Coordinating Center: The Coordinating Center is responsible for providing overall leadership and management infrastructure for all research initiatives. In addition, the Coordinating Center will participate as a separate study arm for each Partnering Site’s study, to include participant accrual and participation in the proposed research at the Coordinating Center’s performance site. Therefore, it is expected that the Coordinating Center will have the appropriate experience and resources to function as a research performance site for each Partnering Site. The Coordinating Center and all Partnering Sites should work together to harmonize research protocols, to develop participant accrual strategies, and to analyze data. Plans for interactions between/among the partners should be well-detailed. The plans must include communication, decision-making, allocation of resources, and coordination of research progress and results among all Partnering Sites. Each Partnering Site should also provide an intellectual property plan to resolve potential intellectual and material property issues and to remove multi-institutional barriers that might interfere with achieving high levels of cooperation to ensure the successful completion of this award. The Coordinating Center should describe prior experience with administration of multi-institutional research initiatives. The Coordinating Center must be from a different institution than the Partnering Sites.Role of the Partnering Sites: A minimum of two Partnering Sites is required. Each Partnering Site should develop its own unique research initiative as relevant to the overall application design. All Partnering Sites must have appropriate experience, resources, and participant accrual experience toward initiating research activities that will be harmonized with the Coordinating Center. Each Partnering Site should detail a research initiative that is unique from the other Partnering Sites. The Coordinating Center Applicant Organization will submit and be designated as the PI; the other partner(s) will be designated as the Co-PI(s). The Partnering Sites Applicant Organizations must be from different institutions.
Eligibility
Grants.gov lists this opportunity under eligibility category code 99. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
More from Defense Health Agency Contracting Activity - DHACA
DoW Neurofibromatosis Synergistic Idea Award
DoW Neurofibromatosis Investigator-Initiated Research Award
DoW Neurofibromatosis Research Academy – Scholar Award
DoW Neurofibromatosis Exploration-Hypothesis Development Award
DOW Combat Readiness – Medical Research Program Translational Research Award
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |